Lucid Group, Inc. LCID

NAS: LCID | ISIN: US5494981039   3/05/2024
2,785 USD (+0,18%)
(+0,18%)   3/05/2024

17 april 2024 · The 2024 Lucid Air Grand Touring: The Longest-Range EV Gets Even Better · Persbericht

9 april 2024 · Lucid Announces Q1 Production & Deliveries, Sets Date for First Quarter 2024 Results · Persbericht

25 maart 2024 · Lucid Group, Inc. Announces Investment of $1.0 Billion by an Affiliate of PIF · Persbericht

29 februari 2024 · Lucid va de l'avant : à Genève, le constructeur américain présente de nouvelles voitures électriques et ses plans d'expansion pour l'Europe · Persbericht

21 februari 2024 · Lucid Announces Fourth Quarter and Full Year 2023 Financial Results · Persbericht

15 februari 2024 · The Lucid Air Now Starts at $69,900 and Comes with New Benefits that Make It Easier than Ever to Own America's Most Awarded New Luxury Electric Vehicle · Persbericht

30 januari 2024 · Lucid Appoints Matt Everitt as General Counsel · Persbericht

11 januari 2024 · Lucid Announces Q4 Production & Deliveries, Sets Date for Fourth Quarter 2023 Results · Persbericht

11 december 2023 · Lucid Announces Departure of Chief Financial Officer Sherry House · Persbericht

5 december 2023 · Lucid Air Model Line Updates Offer Customers More Freedom with the Power of Choice and Greater Flexibility · Persbericht

5 december 2023 · Lucid Air Pure Named to Car and Driver's 10Best List in its First Year of Eligibility · Persbericht

9 november 2023 · Introducing RangeXchange, an Innovative New Feature Enabling the Lucid Air to Directly Charge Other Electric Vehicles · Persbericht

7 november 2023 · Lucid Welcomes Marc Winterhoff as Chief Operating Officer · Persbericht

7 november 2023 · Lucid Announces Third Quarter 2023 Financial Results · Persbericht

6 november 2023 · Lucid to Adopt North American Charging Standard (NACS), Bringing Greater Convenience to Lucid Customers · Persbericht

1 november 2023 · Thinking about buying stock in AERWINS Technologies, Arista Networks, Lucid Group, C3.ai, or Coherus Biosciences? · Persbericht

25 oktober 2023 · Thinking about buying stock in Bitfarms, Invo Bioscience, Lucid Group, EngageSmart, or ESSA Pharma? · Persbericht

24 oktober 2023 · Thinking about buying stock in Bitfarms, Invo Bioscience, Lucid Group, EngageSmart, or ESSA Pharma? · Persbericht

23 oktober 2023 · Lucid Introduces U.S. Referral Program Benefiting Current and Future Owners · Persbericht

20 oktober 2023 · Thinking about buying stock in Ardelyx, Rivian Automotive, Femasys, Lucid Group, or Outlook Therapeutics? · Persbericht

Mijn selecties